Press coverage about Validus (NYSE:VR) has trended somewhat positive on Monday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Validus earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned media coverage about the insurance provider an impact score of 47.5840853576805 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

VR has been the subject of several research reports. Buckingham Research initiated coverage on shares of Validus in a research note on Monday, September 11th. They set a “buy” rating and a $52.00 price objective for the company. ValuEngine raised shares of Validus from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Bank of America raised shares of Validus from a “neutral” rating to a “buy” rating in a research note on Monday, October 30th. TheStreet cut shares of Validus from a “b” rating to a “c+” rating in a research note on Wednesday, October 11th. Finally, Barclays reduced their target price on shares of Validus from $57.00 to $53.00 and set an “equal weight” rating on the stock in a report on Monday, October 16th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. Validus has an average rating of “Hold” and a consensus target price of $54.83.

Validus (NYSE VR) traded up $0.66 during trading hours on Monday, hitting $47.43. 1,165,542 shares of the company traded hands, compared to its average volume of 612,503. The company has a current ratio of 0.95, a quick ratio of 0.95 and a debt-to-equity ratio of 0.52. Validus has a 1-year low of $41.15 and a 1-year high of $58.76.

Validus (NYSE:VR) last posted its earnings results on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($3.30) by $0.08. The business had revenue of $407.00 million for the quarter, compared to analyst estimates of $453.04 million. Validus had a negative net margin of 1.38% and a negative return on equity of 0.49%. The business’s quarterly revenue was up 24.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.02 EPS. sell-side analysts forecast that Validus will post -0.16 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be issued a dividend of $0.38 per share. The ex-dividend date is Thursday, December 14th. This represents a $1.52 annualized dividend and a dividend yield of 3.20%. Validus’s payout ratio is -233.84%.

In other Validus news, CEO Lixin Zeng sold 26,136 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $52.10, for a total value of $1,361,685.60. Following the transaction, the chief executive officer now owns 57,855 shares in the company, valued at approximately $3,014,245.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Kean Driscoll sold 6,875 shares of the business’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $50.30, for a total transaction of $345,812.50. The disclosure for this sale can be found here. Insiders own 2.33% of the company’s stock.

WARNING: This piece was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at

About Validus

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Insider Buying and Selling by Quarter for Validus (NYSE:VR)

Receive News & Stock Ratings for Validus Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus Holdings Ltd. and related stocks with our FREE daily email newsletter.